Analytical Method Development and Validation of Tadalafil and Dapoxetine Hydrochloride in Combined Tablet Dosage Form by Rp-Hplc

Authors

DOI:

https://doi.org/10.33974/3d46wb91

Keywords:

Tadalafil, Dapoxetine hydrochloride, RP-HPLC, validation, Method development, 288nm and UV Visible detector

Abstract

The analytical method was developed and validated for determination of Tadalafil and Dapoxetine hydrochloride in combined tablet dosage form by reversed phase high performance liquid chromatography. Thseparation was carried out on SHIMADZU-LC 20AT Column C18 (240 × 4.6mm) 5μm. The mobile phase consists of Acetonitrile: water and0.1 ml triethylamine and 0.5% trifluroacetic acid 75:25 (v/ v) in the ratio of 75:25 at flow rate 1 ml/ min with UV visible detector wavelength at 288nm. The column temperature calibration curve was linear over the concentration range 80-120% μg/ml(r 2 =1). The validation was carried out as per ICH guidelines. The development method was Rapid, Specific, Precise, Accurate, Linear can be used for routine analysis of these drugs from tablet formulation.

Downloads

Download data is not yet available.

Published

08-08-2026

How to Cite

Analytical Method Development and Validation of Tadalafil and Dapoxetine Hydrochloride in Combined Tablet Dosage Form by Rp-Hplc. (2026). International Journal of Research in Pharmaceutical Sciences and Technology, 9(3). https://doi.org/10.33974/3d46wb91

Similar Articles

41-50 of 174

You may also start an advanced similarity search for this article.